Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Inhibikase Therapeutics, Inc.

Get SEC filing alerts via email and in your feed for Inhibikase Therapeutics, Inc.

IKT

Inhibikase Therapeutics, Inc.

Latest news & discussion for Inhibikase Therapeutics, Inc.:

1
1
Inhibikase Therapeutics, Inc. Inhibikase Therapeutics Reports $27.5 Million Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
Inhibikase Therapeutics, Inc. Inhibikase Therapeutics Reports Significant Financial Challenges, Raises $110M in Private Placement

Via official filing (AI summary) | 5 months ago | 0 comments